PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
12.91M
Better than BTAI's estimated revenue of 5.97M.
-2.58M
Worse than BTAI's estimated ebitda of -1.19M.
-0.93
Better than BTAI's estimated eps of -11.87.
-21.85M
Better than BTAI's estimated net income of -30.09M.
-2.58M
Worse than BTAI's estimated ebit of -1.19M.
478.53M
Worse than BTAI's estimated sg&a expense of 311.50M.
Analyze DCF forecasts for the company and compare them with competitors.
1.03M
Better than BTAI's revenue of 375.00K.
-9.97%
Worse than BTAI's revenue growth rate of 0.00%.
-33.41M
Better than BTAI's ebitda of -157.38M.
-3243.20%
Better than BTAI's ebitda margin of -41969.07%.
-34.10M
Better than BTAI's ebit of -157.71M.
-3311.07%
Better than BTAI's ebit margin of -42056.27%.
699.00K
Worse than BTAI's depreciation of 327.00K.
108.91M
Worse than BTAI's total cash of 193.72M.
10573.79%
Worse than BTAI's cash as percentage of revenue of 51660.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
10.13M
Better than BTAI's accounts payable of 10.23M.
983.50%
Better than BTAI's payables as percentage of revenue of 2727.47%.
-366.00K
Better than BTAI's capital expenditure of -139.00K.
-35.53%
Worse than BTAI's capex as percentage of revenue of -37.07%.
4.99%
Better than BTAI's weighted average cost of capital (wacc) of 14.36%.
5.02%
Worse than BTAI's cost of equity of 5.00%.
4.08%
Better than BTAI's cost of debt of 14.70%.
-0.23
Better than BTAI's beta of 0.08.
30.07M
Worse than BTAI's diluted shares outstanding of 2.54M.
1.57M
Better than BTAI's total debt of 102.95M.
49.31M
Better than BTAI's total equity of 3.68M.
50.89M
Worse than BTAI's total capital of 106.62M.
3.09%
Better than BTAI's debt weighting of 96.55%.
96.91%
Better than BTAI's equity weighting of 3.45%.
-32.98M
Better than BTAI's ebiat of -163.51M.
-28.05M
Better than BTAI's unlevered free cash flow of -160.00M.
2.00%
Equal to BTAI's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than BTAI's net debt of 73.09M.
71.33M
Better than BTAI's equity value of -68.25M.
2.37
Better than BTAI's equity value per share of -26.92.